USFDA removes import alert imposed on Divis Laboratories’ Unit-II at Visakhapatnam

15 Nov 2017 Evaluate

The US Food and Drug Administration (USFDA) h as removed the Import Alert 66-40 on Divis Laboratories’ Unit-II at Visakhapatnam. The regulator had earlier imposed the Import Alert on the company’s Unit-II at Visakhapatnam.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.


Divis Lab Share Price

6345.90 -48.75 (-0.76%)
01-Jan-2026 13:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.00
Dr. Reddys Lab 1251.00
Cipla 1501.55
Zydus Lifesciences 912.50
Lupin 2101.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×